Jasmohan S Bajaj1, Leroy R Thacker2, David Leszczyszyn3, Samuel A Taylor3, Douglas M Heuman4, Shekar Raman3, Richard K Sterling4, Muhammad S Siddiqui4, R Todd Stravitz4, Arun J Sanyal4, Puneet Puri4, Velimir Luketic4, Scott Matherly4, Michael Fuchs4, Melanie B White4, Nicole A Noble4, Ariel B Unser4, James B Wade5. 1. Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, Virginia. Electronic address: jsbajaj@vcu.edu. 2. Department of Biostatistics, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, Virginia. 3. Division of Sleep Medicine, Department of Neurology, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, Virginia. 4. Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, Virginia. 5. Division of Clinical Psychology, Department of Psychiatry, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, Virginia.
Abstract
BACKGROUND & AIMS: In patients with cirrhosis, sleep disturbances are assumed to result from hepatic encephalopathy (HE). The effects of obstructive sleep apnea (OSA) on cognition, sleep parameters, or driving in patients with cirrhosis are unclear. METHODS: We performed a cross-sectional and prospective study of 118 subjects. Subjects were assigned to 1 of 4 groups: those with OSA and cirrhosis (without hepatic encephalopathy or ascites, n = 34), those with cirrhosis only (n = 30), those with OSA only (n = 29), and those without OSA or cirrhosis (controls, n = 25). None of the OSA patients were receiving continuous positive airway pressure (CPAP) therapy. Subjects underwent cognitive testing (paper-pencil tests for psychomotor speed and attention, as well as executive function tests), sleep assessment (daytime sleepiness and night-time sleep quality), and a monotonous driving simulation (worsening lane deviations over time indicated poor performance). We also tested patients with OSA, with cirrhosis (n = 10) and without cirrhosis (n = 7), before and after CPAP therapy. RESULTS: Daytime sleepiness and sleep quality were worse in subjects in the OSA groups (with or without cirrhosis) than subjects with cirrhosis alone or controls. Of subjects with only OSA, 36% had impaired psychomotor speed and attention, compared with more than 60% of subjects in both cirrhosis groups. In contrast, executive function was uniformly worse in subjects with OSA, with or without cirrhosis, than groups without OSA. Simulator performance (lane deviations) worsened over time in both OSA groups. CPAP therapy significantly increased executive function and sleep quality, and reduced simulator lane deviations and sleepiness, in OSA subjects with and without cirrhosis. After CPAP therapy, performance on the paper-pencil test improved significantly only in subjects with OSA without cirrhosis. CONCLUSIONS: OSA should be considered in evaluating sleep impairment in patients with cirrhosis. In patients with cirrhosis and OSA, psychomotor speed and attention issues likely are related to cirrhosis, whereas executive function and simulator performance are affected by OSA. CPAP therapy improves executive function and simulator performance in patients with OSA, regardless of cirrhosis.
BACKGROUND & AIMS: In patients with cirrhosis, sleep disturbances are assumed to result from hepatic encephalopathy (HE). The effects of obstructive sleep apnea (OSA) on cognition, sleep parameters, or driving in patients with cirrhosis are unclear. METHODS: We performed a cross-sectional and prospective study of 118 subjects. Subjects were assigned to 1 of 4 groups: those with OSA and cirrhosis (without hepatic encephalopathy or ascites, n = 34), those with cirrhosis only (n = 30), those with OSA only (n = 29), and those without OSA or cirrhosis (controls, n = 25). None of the OSA patients were receiving continuous positive airway pressure (CPAP) therapy. Subjects underwent cognitive testing (paper-pencil tests for psychomotor speed and attention, as well as executive function tests), sleep assessment (daytime sleepiness and night-time sleep quality), and a monotonous driving simulation (worsening lane deviations over time indicated poor performance). We also tested patients with OSA, with cirrhosis (n = 10) and without cirrhosis (n = 7), before and after CPAP therapy. RESULTS:Daytime sleepiness and sleep quality were worse in subjects in the OSA groups (with or without cirrhosis) than subjects with cirrhosis alone or controls. Of subjects with only OSA, 36% had impaired psychomotor speed and attention, compared with more than 60% of subjects in both cirrhosis groups. In contrast, executive function was uniformly worse in subjects with OSA, with or without cirrhosis, than groups without OSA. Simulator performance (lane deviations) worsened over time in both OSA groups. CPAP therapy significantly increased executive function and sleep quality, and reduced simulator lane deviations and sleepiness, in OSA subjects with and without cirrhosis. After CPAP therapy, performance on the paper-pencil test improved significantly only in subjects with OSA without cirrhosis. CONCLUSIONS: OSA should be considered in evaluating sleep impairment in patients with cirrhosis. In patients with cirrhosis and OSA, psychomotor speed and attention issues likely are related to cirrhosis, whereas executive function and simulator performance are affected by OSA. CPAP therapy improves executive function and simulator performance in patients with OSA, regardless of cirrhosis.
Authors: Javier Crespo; Jose Cifrián; Jose Antonio Pinto; Antonio Jiménez-Gómez; Fernando Pons-Romero Journal: Am J Gastroenterol Date: 2003-12 Impact factor: 10.864
Authors: Jasmohan S Bajaj; Muhammad Hafeezullah; Jose Franco; Rajiv R Varma; Raymond G Hoffmann; Joshua F Knox; Darrell Hischke; Thomas A Hammeke; Steven D Pinkerton; Kia Saeian Journal: Gastroenterology Date: 2008-07-22 Impact factor: 22.682
Authors: Andrew Vakulin; Stuart D Baulk; Peter G Catcheside; Nick A Antic; Cameron J van den Heuvel; Jillian Dorrian; R Doug McEvoy Journal: J Clin Sleep Med Date: 2011-06-15 Impact factor: 4.062
Authors: Charmaine A Stewart; Robert R Auger; Robert Auger; Felicity T B Enders; Donna Felmlee-Devine; Glenn E Smith Journal: J Clin Sleep Med Date: 2014-01-15 Impact factor: 4.062
Authors: Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei Journal: Hepatology Date: 2002-03 Impact factor: 17.425
Authors: Kavish R Patidar; Leroy R Thacker; James B Wade; Melanie B White; Edith A Gavis; Andrew Fagan; Richard K Sterling; Michael Fuchs; Mohammad S Siddiqui; Scott Matherly; Richard T Stravitz; Arun J Sanyal; Puneet Puri; Velimir A Luketic; Jasmohan S Bajaj Journal: Dig Dis Sci Date: 2017-03-03 Impact factor: 3.199